Description

CJC-1295 + Ipamorelin combines two research peptides that act through different signalling mechanisms associated with the growth-hormone axis: a GHRH-related analogue and a ghrelin-receptor agonist.

MMRR CJC-1295 + Ipamorelin is listed as a combined research material. Vial size and pricing will be added to the catalogue when finalized. Every MMRR batch is independently third-party tested under the MMRR testing program.

Manufactured in Atlantic Canada. For research purposes only. No dosing or medical-use guidance is provided.

Additional information

Size	10 mg total (5+5)

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 + Ipamorelin”

Independent third-party testing

Every MMRR product batch is independently tested by a third-party laboratory before release. Core analytical testing is designed to confirm identity, chromatographic purity and peptide content, with additional impurity, moisture, residual-solvent, elemental and microbiological testing used where applicable to the product and batch.

Testing is product- and batch-specific. MMRR does not treat a purity percentage as a substitute for identity, content or microbiological testing.

Read about MMRR testing ↗